- Home
- OTLK vs PZG Comparison
OTLK vs PZG Comparison
Compare OTLK & PZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | PZG |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 97.2M |
| IPO Year | 2016 | 1999 |
Fundamental Metrics
Financial Performance| Metric | OTLK | PZG |
|---|---|---|
| Price | $0.56 | $1.19 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 8.1M | 723.7K |
| Earning Date | 02-13-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,413,535.00 | N/A |
| Revenue This Year | $2,048.59 | N/A |
| Revenue Next Year | $142.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.32 |
| 52 Week High | $3.39 | $1.41 |
Technical Indicators
Market Signals| Indicator | OTLK | PZG |
|---|---|---|
| Relative Strength Index (RSI) | 22.80 | 50.98 |
| Support Level | $1.78 | $1.14 |
| Resistance Level | $2.03 | $1.27 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 2.64 | 43.59 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About PZG Paramount Gold Nevada Corp.
Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.